Logo image of T5W.DE

JUST EAT TAKEAWAY (T5W.DE) Stock Fundamental Analysis

FRA:T5W - Deutsche Boerse Ag - NL0012015705 - Common Stock - Currency: EUR

19.025  -0.06 (-0.31%)

Fundamental Rating

3

T5W gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 55 industry peers in the Hotels, Restaurants & Leisure industry. The financial health of T5W is average, but there are quite some concerns on its profitability. T5W is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

T5W had negative earnings in the past year.
In the past year T5W had a positive cash flow from operations.
In the past 5 years T5W always reported negative net income.
In multiple years T5W reported negative operating cash flow during the last 5 years.
T5W.DE Yearly Net Income VS EBIT VS OCF VS FCFT5W.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1B -2B -3B -4B -5B

1.2 Ratios

T5W has a worse Return On Assets (-20.21%) than 76.36% of its industry peers.
The Return On Equity of T5W (-36.91%) is worse than 63.64% of its industry peers.
Industry RankSector Rank
ROA -20.21%
ROE -36.91%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
T5W.DE Yearly ROA, ROE, ROICT5W.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20 -40 -60

1.3 Margins

The Gross Margin of T5W (48.82%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of T5W has declined.
T5W does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 48.82%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.1%
GM growth 5Y-7.82%
T5W.DE Yearly Profit, Operating, Gross MarginsT5W.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

4

2. Health

2.1 Basic Checks

T5W does not have a ROIC to compare to the WACC, probably because it is not profitable.
T5W has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
T5W.DE Yearly Shares OutstandingT5W.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 50M 100M 150M 200M
T5W.DE Yearly Total Debt VS Total AssetsT5W.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 5B 10B 15B

2.2 Solvency

Based on the Altman-Z score of -0.68, we must say that T5W is in the distress zone and has some risk of bankruptcy.
T5W has a worse Altman-Z score (-0.68) than 78.18% of its industry peers.
T5W has a debt to FCF ratio of 13.03. This is a negative value and a sign of low solvency as T5W would need 13.03 years to pay back of all of its debts.
T5W has a Debt to FCF ratio (13.03) which is in line with its industry peers.
A Debt/Equity ratio of 0.21 indicates that T5W is not too dependend on debt financing.
T5W has a Debt to Equity ratio of 0.21. This is amongst the best in the industry. T5W outperforms 87.27% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF 13.03
Altman-Z -0.68
ROIC/WACCN/A
WACC7.37%
T5W.DE Yearly LT Debt VS Equity VS FCFT5W.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B 10B

2.3 Liquidity

A Current Ratio of 1.11 indicates that T5W should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.11, T5W is in the better half of the industry, outperforming 67.27% of the companies in the same industry.
T5W has a Quick Ratio of 1.10. This is a normal value and indicates that T5W is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.10, T5W is in the better half of the industry, outperforming 69.09% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.11
Quick Ratio 1.1
T5W.DE Yearly Current Assets VS Current LiabilitesT5W.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 500M 1B 1.5B 2B 2.5B

5

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 7.54% over the past year.
T5W shows a small growth in Revenue. In the last year, the Revenue has grown by 0.85%.
Measured over the past years, T5W shows a very strong growth in Revenue. The Revenue has been growing by 53.67% on average per year.
EPS 1Y (TTM)7.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%12.37%
Revenue 1Y (TTM)0.85%
Revenue growth 3Y-7.44%
Revenue growth 5Y53.67%
Sales Q2Q%4.97%

3.2 Future

The Earnings Per Share is expected to grow by 60.72% on average over the next years. This is a very strong growth
Based on estimates for the next years, T5W will show a quite strong growth in Revenue. The Revenue will grow by 9.29% on average per year.
EPS Next Y106.68%
EPS Next 2Y69.09%
EPS Next 3Y42.74%
EPS Next 5Y60.72%
Revenue Next Year-14.95%
Revenue Next 2Y-6.46%
Revenue Next 3Y-3.53%
Revenue Next 5Y9.29%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
T5W.DE Yearly Revenue VS EstimatesT5W.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2B 4B 6B 8B
T5W.DE Yearly EPS VS EstimatesT5W.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 2 -2 4 6 8

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for T5W. In the last year negative earnings were reported.
A Price/Forward Earnings ratio of 390.62 indicates a quite expensive valuation of T5W.
T5W's Price/Forward Earnings is on the same level as the industry average.
T5W is valuated expensively when we compare the Price/Forward Earnings ratio to 22.10, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 390.62
T5W.DE Price Earnings VS Forward Price EarningsT5W.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 100 200 300

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, T5W is valued cheaper than 98.18% of the companies in the same industry.
60.00% of the companies in the same industry are cheaper than T5W, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 33.13
EV/EBITDA 2.52
T5W.DE Per share dataT5W.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 15 20

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A more expensive valuation may be justified as T5W's earnings are expected to grow with 42.74% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y69.09%
EPS Next 3Y42.74%

0

5. Dividend

5.1 Amount

No dividends for T5W!.
Industry RankSector Rank
Dividend Yield N/A

JUST EAT TAKEAWAY

FRA:T5W (3/7/2025, 7:00:00 PM)

19.025

-0.06 (-0.31%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)02-26 2025-02-26/amc
Earnings (Next)04-23 2025-04-23
Inst Owners60.3%
Inst Owner ChangeN/A
Ins Owners7.56%
Ins Owner ChangeN/A
Market Cap3.98B
Analysts72.86
Price Target21.1 (10.91%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)11.57%
PT rev (3m)6.41%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-77.82%
EPS NY rev (3m)-38.59%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-8.42%
Revenue NY rev (3m)-20.17%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 390.62
P/S 1.12
P/FCF 33.13
P/OCF 14.15
P/B 0.89
P/tB N/A
EV/EBITDA 2.52
EPS(TTM)-8.13
EYN/A
EPS(NY)0.05
Fwd EY0.26%
FCF(TTM)0.57
FCFY3.02%
OCF(TTM)1.34
OCFY7.07%
SpS17.06
BVpS21.3
TBVpS-3.48
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -20.21%
ROE -36.91%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 48.82%
FCFM 3.37%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.1%
GM growth 5Y-7.82%
F-Score6
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF 13.03
Debt/EBITDA 0.53
Cap/Depr 8.47%
Cap/Sales 4.52%
Interest Coverage N/A
Cash Conversion 16.22%
Profit Quality N/A
Current Ratio 1.11
Quick Ratio 1.1
Altman-Z -0.68
F-Score6
WACC7.37%
ROIC/WACCN/A
Cap/Depr(3y)6.49%
Cap/Depr(5y)15.71%
Cap/Sales(3y)4.14%
Cap/Sales(5y)3.58%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)7.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%12.37%
EPS Next Y106.68%
EPS Next 2Y69.09%
EPS Next 3Y42.74%
EPS Next 5Y60.72%
Revenue 1Y (TTM)0.85%
Revenue growth 3Y-7.44%
Revenue growth 5Y53.67%
Sales Q2Q%4.97%
Revenue Next Year-14.95%
Revenue Next 2Y-6.46%
Revenue Next 3Y-3.53%
Revenue Next 5Y9.29%
EBIT growth 1Y16%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year285.12%
EBIT Next 3Y65.58%
EBIT Next 5Y44.54%
FCF growth 1Y544.44%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y124.8%
OCF growth 3YN/A
OCF growth 5YN/A